Serum anti‐Mullerian hormone is a useful measure of quantitative ovarian reserve but does not predict the chances of live‐birth pregnancy
- 20 September 2010
- journal article
- Published by Wiley in Australian and New Zealand Journal of Obstetrics and Gynaecology
- Vol. 50 (6) , 568-572
Abstract
Background: Serum anti‐Mullerian hormone (AMH) is an established marker of the number of oocytes left within a woman’s ovaries (quantitative ovarian reserve). However, it is presently unclear if serum AMH also measures oocyte quality and therefore the chances of successful live‐birth pregnancy. The aim of this study was to determine if serum AMH assessed ovarian reserve correlates with chances of live birth (LB) and miscarriage following intra‐uterine insemination (IUI) treatment.Methods: In this retrospective study, serum AMH percentile charts were developed using AMH measurements from 1032 women undergoing routine infertility investigation. A total of 244 women undergoing IUI treatments were classified according to whether they had low (first quartile), normal (second and third quartiles) or high (fourth quartile) serum AMH concentrations relative to their age, and the subsequent pregnancy outcomes were analysed.Results: Serum AMH concentration fell with advancing maternal age and serum AMH concentrations were well correlated with quantitative ovarian reserve (antral follicle counts, AFC). The LB and miscarriage rates in each of the four AMH quartiles did not differ significantly from one another.Conclusions: Serum AMH is a useful marker of quantitative but not qualitative ovarian reserve as it correlates well with AFC, yet bears no relation to chances of live‐birth or miscarriage.Keywords
This publication has 20 references indexed in Scilit:
- Evaluating the performance of serum antimullerian hormone concentration in predicting the live birth rate of controlled ovarian stimulation and intrauterine inseminationFertility and Sterility, 2010
- Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)Human Reproduction Update, 2009
- Serum anti-Müllerian hormone predicts ovarian response and cycle outcome in IVF patientsJournal of Assisted Reproduction and Genetics, 2009
- Anti-Mullerian Hormone and Inhibin B in the Definition of Ovarian Aging and the Menopause TransitionThe Journal of Clinical Endocrinology & Metabolism, 2008
- Serum anti-Mullerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles implications for individualization of therapyHuman Reproduction, 2007
- Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trialHuman Reproduction, 2007
- Oocyte–somatic cell interactions during follicle development in mammalsAnimal Reproduction Science, 2004
- Early ovarian ageing: a hypothesis: Detection and clinical relevanceHuman Reproduction, 2003
- Ovulation induction combined with intrauterine insemination in women 40 years of age and older: is it worthwhile?Human Reproduction, 1996
- Reproductive Span and Rate of Reproduction Among Hutterite WomenFertility and Sterility, 1957